2025 Year in Review: Breakthroughs, Milestones & Moments That Defined ISB
From Nobel recognition and scientific firsts to transformative collaborations and community impact, 2025 marked one of the most significant years in ISB’s 25-year history.
Back to Previous Page
ISB News
Events
-
- All Categories
- Advancing Health
- Autoimmune Diseases
- Baliga Lab
- Brain Health
- Cancer
- Cancer Tipping Points
- Chronic Illness
- Climate Change
- Courses and Symposia
- COVID and Long COVID
- CyberGut
- Early Detection and Diagnosis
- Education
- Environment
- Events
- Fellows
- Gibbons Lab
- Hadlock Lab
- Hands-on Learning
- Health
- Health Data Science Lab
- Health Equity
- Healthspan and Longevity
- Heath Lab
- Hood Lab
- Huang Lab
- Infectious Disease
- Internships
- ISB-Town Hall
- Kane Lab
- Kuchina Lab
- Logan Center for Education
- Lyme Disease
- Malaria
- Maternal and Infant Health
- Microbiome
- Moritz Lab
- My Digital Gut
- Neurological Disorders
- Optimizing Outcomes
- People
- Philanthropy
- Precision Treatments
- Press Release
- Proteins and Disease
- Ranish Lab
- Real-world Science
- Research Roundtable
- Subramanian Lab
- Sustainability and Remediation
- SYGNAL
- Systemic Change
- Systems Education Experiences
- Thorsson-Shmulevich Lab
- Treatments and Resistance
- Tuberculosis
- Understanding Tumors
- Venkatesh Lab
- Wei Lab
Sort
-
- Default
- A-Z
- Z-A
- Newest
- Oldest
Microbial Metabolites and Human Health Take Center Stage at ISB’s 2025 Virtual Microbiome Symposium
Six leading experts from across the field presented new insights to more than 1,000 registrants worldwide, with over 400 participants joining live.
What We’re Learning About Long COVID: Updates from the PNW RECOVER Town Hall
At a recent virtual town hall, leaders of the Pacific Northwest RECOVER hub shared what they’ve learned so far about long COVID — from symptom trajectories and genetic risk to early trial results and upcoming studies — and answered questions from participants about risk factors, persistent symptoms and what comes next.
Eric Topol and Lee Hood — Two Scientific Luminaries on Longevity and Prevention
Discussing Super Agers, Drs. Eric Topol and Lee Hood connected breakthroughs in genomics, AI, and lifestyle science to the pursuit of longer, healthier lives.
RECOVER 2.0: New Insights and Next Steps in Long COVID Research
Researchers from the NIH-funded RECOVER study shared new insights on the risks of Long COVID, autoimmune links, and upcoming clinical trials during ISB’s July Town Hall.
How Generative AI Is Helping Decode the Human Immune System
In a Research Roundtable presentation and Q&A, ISB President Dr. Jim Heath shared how his team is using generative AI to unlock new understanding of human immunity, and how these discoveries could help predict disease severity, improve cancer therapies, and more.